|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2600 USD | -1.89% |
|
-10.34% | -51.85% |
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| 05-15 | Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Guided Therapeutics, Inc.
Delayed Quote OTC Markets
| 16/06/2026 | 17/06/2026 | 18/06/2026 | 22/06/2026 | 23/06/2026 | |
|---|---|---|---|---|---|
| Last | US$0.2480 | US$0.2900 | US$0.2900 | US$0.2650 | US$0.2600 |
| Volume | 34,672 | 14,950 | 18,292 | 250 | 14,600 |
| Change | +27.70% | +16.94% | 0.00% | -8.62% | -1.89% |
| Opening | US$0.2250 | US$0.2485 | US$0.3399 | US$0.2650 | US$0.2600 |
| High | US$0.2500 | US$0.2900 | US$0.3399 | US$0.2650 | US$0.2600 |
| Low | US$0.2077 | US$0.2485 | US$0.2500 | US$0.2650 | US$0.2200 |
Performance
| 1 day | -1.89% | ||
| 1 week | -10.34% | ||
| Current month | +13.54% | ||
| 1 month | +44.44% | ||
| 3 months | +4.00% | ||
| 6 months | -21.80% | ||
| Current year | -51.85% | ||
| 1 year | +13.04% | ||
| 3 years | +44.44% | ||
| 5 years | -61.17% | ||
| 10 years | -99.99% |
Volumes
marketsDaily volume
14,600
Estimated daily volume
14,600
Avg. Volume 20 sessions
8,301
Daily volume ratio
1.76
Avg. Volume 20 sessions USD
2,158.26
Record volume 1
651,663
Record volume 2
513,070
Record volume 3
477,539
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
25,099,710
Net sales ()
767,000
Number of employees
3
Sales / Employee (USD)
255,667
Free-Float
63.48 %
Free-Float capitalization (USD)
15,933,972
Average Daily Capital Traded
0.01%
Indicators
Moving average 5 days
0.2763
Moving average 20 days
0.1934
Moving average 50 days
0.192
Moving average 100 days
0.2626
Price spread / (MMA5)
+6.27%
Price spread / (MMA20)
-25.62%
Price spread / (MMA50)
-26.15%
Price spread / (MMA100)
+1.00%
STIM
RSI 9 days
54.41
RSI 14 days
53.07
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.89% | -10.34% | +13.04% | +44.44% | 25.1M | |
| +4.87% | +6.61% | +21.72% | -6.11% | 174B | |
| -0.33% | -0.09% | -23.18% | +22.79% | 143B | |
| +5.53% | +6.25% | -4.36% | -20.70% | 127B | |
| -2.50% | -1.09% | -57.30% | -17.62% | 67.78B | |
| +3.12% | +3.44% | +18.21% | -0.75% | 50.07B | |
| -0.84% | -1.21% | -27.01% | -33.20% | 43.84B | |
| +3.92% | +5.87% | +11.89% | +10.22% | 35.78B | |
| +3.35% | +3.41% | +6.45% | +42.08% | 35.07B | |
| +1.82% | +6.10% | -9.86% | -18.72% | 28.99B | |
| Average | +1.70% | +0.52% | -5.04% | +2.24% | 70.54B | |
| Weighted average by Cap. | +2.50% | +0.76% | -5.48% | -2.58% |
Historical Quotes: Guided Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 0.22 |  | 0.26 |
| 1 month | 0.18 | | 0.34 |
| Current year | 0.17 | | 0.54 |
| 1 year | 0.12 | | 0.54 |
| 3 years | 0.06 | | 0.54 |
| 5 years | 0.06 | | 0.78 |
| 10 years | 0.02 | | 9,280 |
Monthly variations
Annual variations
| 2026 | -51.85% | ||
| 2025 | +260.00% | ||
| 2024 | -2.28% | ||
| 2023 | -48.83% | ||
| 2022 | -48.29% | ||
| 2021 | +93.46% | ||
| 2020 | +125.49% | ||
| 2019 | -44.58% | ||
| 2018 | -98.80% | ||
| 2017 | -95.36% | ||
| 2016 | -99.96% | ||
| 2015 | -93.48% | ||
| 2014 | -52.10% | ||
| 2013 | -29.41% | ||
| 2012 | -55.26% | ||
| 2011 | +90.00% | ||
| 2010 | -28.57% | ||
| 2009 | +460.00% | ||
| 2008 | +5.26% | ||
| 2007 | -36.67% | ||
| 2006 | +20.00% | ||
| 2005 | -50.98% | ||
| 2004 | -74.50% | ||
| 2003 | +24.22% | ||
| 2002 | -76.67% | ||
| 2001 | -6.44% | ||
| 2000 | -38.22% | ||
| 1999 | +97.93% | ||
| 1998 | -10.65% | ||
| 1997 | -3.57% |
- Stock Market
- Stocks
- GTHP Stock
- Quotes Guided Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
